• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺腺鳞癌的临床病理特征及手术结果:对可切除阶段肿瘤患者的回顾性分析

Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors.

作者信息

Komatsu Hirotake, Egawa Shinichi, Motoi Fuyuhiko, Morikawa Takanori, Sakata Naoaki, Naitoh Takeshi, Katayose Yu, Ishida Kazuyuki, Unno Michiaki

机构信息

Department of Surgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.

出版信息

Surg Today. 2015 Mar;45(3):297-304. doi: 10.1007/s00595-014-0934-0. Epub 2014 Jun 29.

DOI:10.1007/s00595-014-0934-0
PMID:24973941
Abstract

PURPOSE

Adenosquamous carcinoma of the pancreas is a rare subtype of pancreatic cancer. We herein describe the clinicopathological features of surgically resected cases of adenosquamous carcinoma of the pancreas.

METHODS

From 2001 to 2011, 132 patients underwent R0 resection for Stage IIA or IIB pancreatic cancer. The survival rate, pathological features and recurrence status were reviewed.

RESULTS

Out of 132 patients, 121 patients had tubular adenocarcinoma, and only seven had adenosquamous carcinoma (ASC). The incidence of ASC increased with the tumor size. The overall survival and disease-free survival periods of the patients with ASC were significantly shorter than those of patients with tubular adenocarcinoma (p = 0.0153 and p = 0.0045). The histological findings revealed more marked venous invasion in ASC compared to tubular adenocarcinoma (G1, G2 and G3). The proportion of v3 cases, which denotes the most severe venous invasion, was 31.3 % in G1, 47.3 % in G2, 60.0 % in G3 and 71.4 % in ASC cases, respectively. Other factors, including lymphatic and nerve invasion, were not correlated with the histological subtypes. The incidence of ASC was 11.1 % in the tumors more than 6 cm in diameter, and 0 % in those less than 2 cm in diameter.

CONCLUSIONS

We revealed that adenosquamous carcinoma of the pancreas is associated with a poor outcome, and also clarified its clinicopathological features.

摘要

目的

胰腺腺鳞癌是胰腺癌的一种罕见亚型。我们在此描述手术切除的胰腺腺鳞癌病例的临床病理特征。

方法

2001年至2011年,132例患者接受了IIA期或IIB期胰腺癌的R0切除。回顾了生存率、病理特征和复发情况。

结果

132例患者中,121例患有管状腺癌,仅7例患有腺鳞癌(ASC)。ASC的发病率随肿瘤大小增加而升高。ASC患者的总生存期和无病生存期明显短于管状腺癌患者(p = 0.0153和p = 0.0045)。组织学检查发现,与管状腺癌(G1、G2和G3)相比,ASC中的静脉侵犯更为明显。表示最严重静脉侵犯的v3病例比例在G1中为31.3%,在G2中为47.3%,在G3中为60.0%,在ASC病例中为71.4%。包括淋巴和神经侵犯在内的其他因素与组织学亚型无关。直径大于6 cm的肿瘤中ASC的发病率为11.1%,直径小于2 cm的肿瘤中ASC的发病率为0%。

结论

我们发现胰腺腺鳞癌与不良预后相关,并阐明了其临床病理特征。

相似文献

1
Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors.胰腺腺鳞癌的临床病理特征及手术结果:对可切除阶段肿瘤患者的回顾性分析
Surg Today. 2015 Mar;45(3):297-304. doi: 10.1007/s00595-014-0934-0. Epub 2014 Jun 29.
2
Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma.胰腺腺鳞癌手术后的临床病理特征及预后
World J Surg Oncol. 2008 Sep 3;6:95. doi: 10.1186/1477-7819-6-95.
3
Squamous/adenosquamous carcinoma of the gallbladder: Analysis of 34 cases and comparison of clinicopathologic features and surgical outcomes with adenocarcinoma.胆囊鳞状/腺鳞癌:34例分析及与腺癌临床病理特征和手术结果的比较
J Surg Oncol. 2015 Nov;112(6):677-80. doi: 10.1002/jso.24065. Epub 2015 Oct 13.
4
Long-term outcomes after an aggressive resection of adenosquamous carcinoma of the pancreas.胰腺腺鳞癌积极切除后的长期预后。
Surg Today. 2019 Oct;49(10):809-819. doi: 10.1007/s00595-019-01807-8. Epub 2019 Apr 12.
5
Comparative outcomes of adenosquamous carcinoma of the pancreas: An analysis of the National Cancer Database.胰腺腺鳞癌的比较结果:一项基于国家癌症数据库的分析。
J Surg Oncol. 2018 Jul;118(1):21-30. doi: 10.1002/jso.25112. Epub 2018 Jun 7.
6
Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.胰腺腺鳞癌的临床特征和预后 - 与胰腺导管腺癌的配对分析。
Eur J Surg Oncol. 2021 Jul;47(7):1734-1741. doi: 10.1016/j.ejso.2021.02.011. Epub 2021 Feb 16.
7
Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.比较 FIGO 分期 I 期至 II 期宫颈腺鳞癌和腺癌患者接受根治性子宫切除术的预后。
Int J Gynecol Cancer. 2012 Oct;22(8):1389-97. doi: 10.1097/IGC.0b013e31826b5d9b.
8
415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival.415 例胰腺腺鳞癌患者:基于人群的预后和生存分析。
J Surg Res. 2012 May 1;174(1):12-9. doi: 10.1016/j.jss.2011.06.015. Epub 2011 Jul 7.
9
Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder.ROR2和WNT5a在胆囊鳞癌/腺鳞癌与腺癌中表达的比较研究
World J Gastroenterol. 2017 Apr 14;23(14):2601-2612. doi: 10.3748/wjg.v23.i14.2601.
10
Surgical outcome of adenosquamous carcinoma of the pancreas.胰腺腺鳞癌的手术结果
World J Gastroenterol. 2008 Nov 28;14(44):6765-70. doi: 10.3748/wjg.14.6765.

引用本文的文献

1
A case of pancreatic adenosquamous cell carcinoma with a pseudocyst following curative surgery.一例根治性手术后出现假性囊肿的胰腺腺鳞癌病例。
Surg Case Rep. 2024 Apr 1;10(1):74. doi: 10.1186/s40792-024-01868-z.
2
Adenosquamous carcinoma coexisting with intraductal papillary mucinous neoplasm of the pancreas: a case report.胰腺腺鳞癌合并胰腺导管内乳头状黏液性肿瘤:一例报告。
J Med Case Rep. 2023 Mar 2;17(1):72. doi: 10.1186/s13256-023-03798-0.
3
Pancreatic Adenosquamous Carcinoma: A Rare Pathological Subtype of Pancreatic Cancer.

本文引用的文献

1
Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis.胰腺的腺鳞癌与腺癌:基于人群的结局分析。
J Gastrointest Surg. 2011 Jan;15(1):165-74. doi: 10.1007/s11605-010-1378-5. Epub 2010 Nov 17.
2
Clinicopathological features of adenosquamous pancreatic cancer.腺鳞胰腺癌的临床病理特征。
Langenbecks Arch Surg. 2011 Feb;396(2):217-22. doi: 10.1007/s00423-010-0677-3. Epub 2010 Jul 9.
3
Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?
胰腺腺鳞癌:一种罕见的胰腺癌病理亚型。
J Clin Med. 2022 Dec 14;11(24):7401. doi: 10.3390/jcm11247401.
4
Pancreatic Adenosquamous Carcinoma: Experience Within an Integrated Health Care System.胰腺腺鳞癌:在综合性医疗保健系统中的经验。
Perm J. 2023 Jun 15;27(2):9-12. doi: 10.7812/TPP/22.095. Epub 2022 Nov 6.
5
Locally Advanced Pancreatic Ductal Adenocarcinoma: Challenges and Progress.局部进展期胰腺导管腺癌:挑战与进展
Onco Targets Ther. 2020 Dec 10;13:12705-12720. doi: 10.2147/OTT.S220971. eCollection 2020.
6
Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology.胰腺癌细胞变体的形态学和分子特征,为精准肿瘤学的新治疗策略奠定基础。
Int J Mol Sci. 2020 Nov 22;21(22):8841. doi: 10.3390/ijms21228841.
7
Prognostic and predictive factors in pancreatic cancer.胰腺癌的预后因素和预测因素。
Oncotarget. 2020 Mar 10;11(10):924-941. doi: 10.18632/oncotarget.27518.
8
Impact of resection margins on long-term survival after pancreaticoduodenectomy for pancreatic head carcinoma.切缘对胰头癌胰十二指肠切除术后长期生存的影响。
World J Clin Cases. 2019 Dec 26;7(24):4186-4195. doi: 10.12998/wjcc.v7.i24.4186.
9
Chemoradiotherapy is associated with improved survival for resected pancreatic adenosquamous carcinoma: a retrospective cohort study from the SEER database.化疗放疗与切除的胰腺腺鳞癌患者生存率提高相关:一项来自监测、流行病学和最终结果(SEER)数据库的回顾性队列研究
Ann Transl Med. 2019 Oct;7(20):522. doi: 10.21037/atm.2019.10.12.
10
Pathology of pancreatic cancer.胰腺癌的病理学
Transl Gastroenterol Hepatol. 2019 Jun 27;4:50. doi: 10.21037/tgh.2019.06.02. eCollection 2019.
肺腺鳞癌是腺癌和鳞癌的简单混合,还是在分子水平上更复杂?
Lung Cancer. 2010 Apr;68(1):1-9. doi: 10.1016/j.lungcan.2009.11.001. Epub 2009 Dec 8.
4
Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma.胰腺腺鳞癌具有与胰腺导管腺癌相似的KRAS2、DPC4和TP53分子改变。
Mod Pathol. 2009 May;22(5):651-9. doi: 10.1038/modpathol.2009.15. Epub 2009 Mar 6.
5
Surgical outcome of adenosquamous carcinoma of the pancreas.胰腺腺鳞癌的手术结果
World J Gastroenterol. 2008 Nov 28;14(44):6765-70. doi: 10.3748/wjg.14.6765.
6
Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma.胰腺腺鳞癌手术后的临床病理特征及预后
World J Surg Oncol. 2008 Sep 3;6:95. doi: 10.1186/1477-7819-6-95.
7
Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.胰腺腺鳞癌:单机构关于手术切除与姑息治疗比较的经验
J Am Coll Surg. 2008 Sep;207(3):368-70. doi: 10.1016/j.jamcollsurg.2008.03.027. Epub 2008 May 15.
8
Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.mortalin(HSPA9)与肝癌转移的关联及早期肿瘤复发预测
Mol Cell Proteomics. 2008 Feb;7(2):315-25. doi: 10.1074/mcp.M700116-MCP200. Epub 2007 Oct 14.
9
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.吉西他滨辅助化疗与胰腺癌根治性切除术后观察对比:一项随机对照试验
JAMA. 2007 Jan 17;297(3):267-77. doi: 10.1001/jama.297.3.267.
10
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.全球范围内子宫颈腺癌的人乳头瘤病毒病因及其辅助因素:对筛查和预防的意义
J Natl Cancer Inst. 2006 Mar 1;98(5):303-15. doi: 10.1093/jnci/djj067.